Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries.

[1]  R. Gamelli,et al.  Thrombospondin 1 synthesis and function in wound repair. , 1996, The American journal of pathology.

[2]  J. Isner,et al.  Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. , 1996, Circulation.

[3]  M. Reed,et al.  Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. , 1995, The American journal of pathology.

[4]  P. Zech,et al.  Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis. , 1994, The American journal of pathology.

[5]  J. Isner,et al.  Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. , 1994, The American journal of pathology.

[6]  U. Ryan,et al.  Thrombospondin mediates migration and potentiates platelet‐derived growth factor‐dependent migration of calf pulmonary artery smooth muscle cells , 1993, Journal of cellular physiology.

[7]  J. Lahav.  The functions of thrombospondin and its involvement in physiology and pathophysiology. , 1993, Biochimica et biophysica acta.

[8]  M. Ferguson,et al.  Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.

[9]  M. Rekhter,et al.  Cell proliferation in human arteriovenous fistulas used for hemodialysis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  J. Lawler,et al.  Diverse mechanisms for cell attachment to platelet thrombospondin. , 1993, Journal of cell science.

[11]  F M Watt,et al.  Regulation of development and differentiation by the extracellular matrix. , 1993, Development.

[12]  J. Isner,et al.  Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. , 1993, The Journal of clinical investigation.

[13]  S. Schnitt,et al.  Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. , 1993, The American journal of cardiology.

[14]  J. Lawler,et al.  Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family , 1993, The Journal of cell biology.

[15]  J. Miano,et al.  Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  J. Isner,et al.  Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. , 1992, Journal of the American College of Cardiology.

[17]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[18]  P. Bornstein,et al.  Thrombospondins: structure and regulation of expression , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Ward Casscells,et al.  Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis , 1992, Circulation.

[20]  R. Kramer,et al.  β1 And β3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix , 1992 .

[21]  C. Corless,et al.  Colocalization of thrombospondin and syndecan during murine development , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  Y Okada,et al.  Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  J. Isner,et al.  A new balloon-expandable tantalum coil stent: angiographic patency and histologic findings in an atherogenic swine model. , 1992, Journal of the American College of Cardiology.

[24]  P. Bornstein,et al.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.

[25]  M. Sporn,et al.  Cytokines in context , 1991, The Journal of cell biology.

[26]  M. Fishbein,et al.  A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. , 1991, Journal of the American College of Cardiology.

[27]  M. Nobuyoshi,et al.  Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. , 1991, Journal of the American College of Cardiology.

[28]  D. Lane,et al.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms , 1990, The Journal of pathology.

[29]  R D Safian,et al.  Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. , 1990, Circulation.

[30]  M. Mayberg,et al.  Thrombospondin deposition in rat carotid artery injury. , 1990, The American journal of pathology.

[31]  V. Fuster,et al.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.

[32]  J. Simpson,et al.  Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. , 1990, Journal of the American College of Cardiology.

[33]  N. Kieffer,et al.  Identification of platelet membrane thrombospondin binding molecules using an anti-thrombospondin antibody. , 1988, Biochimica et biophysica acta.

[34]  P. Cipriano,et al.  Transluminal atherectomy for occlusive peripheral vascular disease. , 1988, The American journal of cardiology.

[35]  V. Dixit,et al.  Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation , 1988, The Journal of cell biology.

[36]  V. Dixit,et al.  Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. , 1987, The Journal of biological chemistry.

[37]  A. Gown,et al.  Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. , 1986, Arteriosclerosis.

[38]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[39]  R. Silverstein,et al.  Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. , 1986, The Journal of biological chemistry.

[40]  J. Lawler.  The structural and functional properties of thrombospondin. , 1986, Blood.

[41]  P. Bornstein,et al.  Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells , 1985, The Journal of cell biology.

[42]  P. Bornstein,et al.  Light microscopic immunolocation of thrombospondin in human tissues. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  P. Bornstein,et al.  Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen , 1984, The Journal of cell biology.

[44]  P. Bornstein,et al.  Thrombospondin: synthesis and secretion by cells in culture , 1982, The Journal of cell biology.

[45]  J. Coligan,et al.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. , 1978, The Journal of biological chemistry.

[46]  A. Gown,et al.  HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. , 1987, The American journal of pathology.